Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Staging
5 results:

  • 1. Impact of cxcr4-Directed PET/CT on staging and Proposed Oncologic Management in Patients With Digestive System Tumors.
    Weich A; Serfling SE; Schlötelburg W; Higuchi T; Hartrampf PE; Schirbel A; Heinrich M; Buck AK; Rowe SP; Kosmala A; Werner RA
    Clin Nucl Med; 2023 Jul; 48(7):586-593. PubMed ID: 37167408
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of cxcr4 and CD133 co-expression on the prognosis of patients with stage II~III colon cancer.
    Li XF; Guo XG; Yang YY; Liu AY
    Asian Pac J Cancer Prev; 2015; 16(3):1073-6. PubMed ID: 25735334
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of cxcr4 expression.
    Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ
    Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CD 133+ and cxcr4+ colon cancer cells as a marker for lymph node metastasis.
    Silinsky J; Grimes C; Driscoll T; Green H; Cordova J; Davis NK; Li L; Margolin DA
    J Surg Res; 2013 Nov; 185(1):113-8. PubMed ID: 23777983
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Imaging cxcr4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.
    De Silva RA; Peyre K; Pullambhatla M; Fox JJ; Pomper MG; Nimmagadda S
    J Nucl Med; 2011 Jun; 52(6):986-93. PubMed ID: 21622896
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.